This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Alpha-9 Oncology Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Stephen Barigye and GRPR-Targeted Innovation
Introduction
Stephen Barigye is an inventor associated with Vancouver, Canada, and Alpha-9 Oncology Inc. His patent work concerns compounds targeting the gastrin-releasing peptide receptor (GRPR).
Latest Patents
Barigye is listed as an inventor on one patent: “Gastrin-Releasing Peptide Receptor (GRPR)-Targeted Compounds and Uses Thereof.” The patent describes compounds directed at GRPR and their potential uses. The available information does not establish whether this is his latest patent.
Career Highlights
Barigye’s recorded patent portfolio includes 1 patent. His listed company affiliation is Alpha-9 Oncology Inc.
Collaborations
His named collaborators include Jutta Wanner and Chengcheng Zhang, who are also associated with the patent.
Conclusion
Stephen Barigye’s documented innovation centers on GRPR-targeted compounds, developed in connection with Alpha-9 Oncology Inc.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile